# Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

> **NCT02652715** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 29 (actual)

## Conditions studied

- Adult Nasal Type Extranodal NK/T-Cell Lymphoma
- Adult T-Cell Leukemia/Lymphoma
- Anaplastic Large Cell Lymphoma
- Angioimmunoblastic T-Cell Lymphoma
- B Lymphoblastic Leukemia/Lymphoma
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Burkitt Leukemia
- Central Nervous System Lymphoma
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Diffuse Large B-Cell Lymphoma
- Enteropathy-Associated T-Cell Lymphoma
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- Grade 1 Follicular Lymphoma
- Grade 2 Follicular Lymphoma
- Grade 3 Follicular Lymphoma
- Hepatosplenic T-Cell Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle Cell Lymphoma
- Mediastinal (Thymic) Large B-Cell Lymphoma
- Mycosis Fungoides
- Nasal Type Extranodal NK/T-Cell Lymphoma
- Nodal Marginal Zone Lymphoma
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Post-Transplant Lymphoproliferative Disorder
- Primary Cutaneous Anaplastic Large Cell Lymphoma
- Primary Effusion Lymphoma
- Sezary Syndrome
- Splenic Marginal Zone Lymphoma
- Subcutaneous Panniculitis-Like T-Cell Lymphoma
- Systemic Anaplastic Large Cell Lymphoma
- T Lymphoblastic Leukemia/Lymphoma
- Transformed Recurrent Non-Hodgkin Lymphoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **DIETARY_SUPPLEMENT:** Salvia hispanica Seed

## Key facts

- **NCT ID:** NCT02652715
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-19
- **Primary completion:** 2018-12-21
- **Final completion:** 2019-11-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2019-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02652715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02652715, "Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02652715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*